PHARMAS HURT
17/08/22 -"Zantac and Biden seem to have taken the wind from even the strongest pharma groups' sails with the sector being the worst performer last week and down nearly 5% over the last month. So much for a ..."
Pages
41
Language
English
Published on
17/08/22
You may also be interested by these reports :
18/09/25
For FY25, the increase in EPS is driven by stronger than expected results in both revenue and adjusted EBIT. Organic sales growth was primarily ...
17/09/25
Ferguson’s Q4 FY25 results surpassed expectations, with revenue rising 6.9% yoy in Q4. The non-residential business led growth, especially in the US. ...
16/09/25
Our estimates have been trimmed as a result of the moderation of organic growth in recent quarters, which include volume-related challenges ...
10/09/25
Inditex reported a slightly below-consensus H1 25 performance, but the new Autumn Winter collections have been very well received, with the top line ...